1. Home
  2. NSPR vs LSF Comparison

NSPR vs LSF Comparison

Compare NSPR & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • LSF
  • Stock Information
  • Founded
  • NSPR 2005
  • LSF 2015
  • Country
  • NSPR United States
  • LSF United States
  • Employees
  • NSPR N/A
  • LSF N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • LSF Packaged Foods
  • Sector
  • NSPR Health Care
  • LSF Consumer Staples
  • Exchange
  • NSPR Nasdaq
  • LSF Nasdaq
  • Market Cap
  • NSPR 75.1M
  • LSF 65.5M
  • IPO Year
  • NSPR N/A
  • LSF 2020
  • Fundamental
  • Price
  • NSPR $2.44
  • LSF $7.38
  • Analyst Decision
  • NSPR Strong Buy
  • LSF Strong Buy
  • Analyst Count
  • NSPR 2
  • LSF 2
  • Target Price
  • NSPR $4.50
  • LSF $12.00
  • AVG Volume (30 Days)
  • NSPR 386.2K
  • LSF 27.6K
  • Earning Date
  • NSPR 08-05-2025
  • LSF 08-06-2025
  • Dividend Yield
  • NSPR N/A
  • LSF N/A
  • EPS Growth
  • NSPR N/A
  • LSF N/A
  • EPS
  • NSPR N/A
  • LSF N/A
  • Revenue
  • NSPR $7,027,000.00
  • LSF $45,040,358.00
  • Revenue This Year
  • NSPR $4.85
  • LSF $23.40
  • Revenue Next Year
  • NSPR $113.47
  • LSF $20.11
  • P/E Ratio
  • NSPR N/A
  • LSF N/A
  • Revenue Growth
  • NSPR 8.49
  • LSF 25.04
  • 52 Week Low
  • NSPR $1.99
  • LSF $3.40
  • 52 Week High
  • NSPR $3.80
  • LSF $10.90
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 54.16
  • LSF 57.20
  • Support Level
  • NSPR $2.12
  • LSF $6.03
  • Resistance Level
  • NSPR $2.46
  • LSF $6.74
  • Average True Range (ATR)
  • NSPR 0.16
  • LSF 0.31
  • MACD
  • NSPR 0.01
  • LSF 0.05
  • Stochastic Oscillator
  • NSPR 73.33
  • LSF 66.67

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

Share on Social Networks: